Trump tariffs drive pharma manufacturing to US but risk inflation and disruption

URLhttps://www.pharmaceutical-technology.com/analyst-
SourcePharmaceuticals Technology
Date Published03/25/2025

Additional Reshoring Information:

Company/Division name Pending tariffs--Pfizer
Parent companyPfizer
Type of work Manufacturing
Reshoring category:Reshoring
Year reshoring announced:2025
If relevant, work nearshored to:-
Industry(ies):Chemicals
Product(s) reshoredpharma
What non-domestic negative factors made offshoring less attractive?Tariffs
Find Reshoring Articles